CAPE TOWN, South Africa (AP) — U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug, the country’s antitrust regulator said Friday.
J&J’s Belgium-based subsidiary Janssen Pharmaceuticals is also under investigation, South Africa’s Competition Commission said.
The commission, which…